Management plans to file for regulatory approval of "Tresmi" for PAH and ILD this year, with commercial launch targeted for next year. Tyvaso DPI platform enhancement -- Introduction of 80-microgram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results